A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
Clinical trial NCT05110976 · COMPLETED
Trial details
- NCT number
- NCT05110976
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2023-08-02
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.